We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Judge Upholds UTC’s Remodulin Patent Against Sandoz ANDA
Judge Upholds UTC’s Remodulin Patent Against Sandoz ANDA
Sandoz must wait until a patent on United Therapeutics Corporation’s pulmonary arterial hypertension drug Remodulin expires in 2017 before it can market a generic version.